Browsing by author "Capote Huelva, Francisco Javier"
Now showing items 1-2 of 2
-
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice
Sancho, Juan-Manuel; Marín‑Niebla, Ana; Fernández, Silvia
; Capote Huelva, Francisco Javier; Cañigral, Carolina; Grande, Carlos; Donato, Eva; Zeberio, Izaskun; Puerta, Jose-Manuel; Rivas, Alfredo; Pérez‑Ceballos, Elena; Vale, Ana; García‑Sancho, Alejandro Martín; Salar, Antonio; González‑Barca, Eva; Teruel, Anabel; Pastoriza, Carmen; Conde‑Royo, Diego; Sánchez‑García, Joaquín; Barrenetxea, Cristina; Arranz, Reyes; Hernández‑Rivas, Jose-Angel; Ramírez, María‑José; Jiménez, Aroa; Rubio‑Azpeitia, Eva (SPRINGER, 2022-05)
-
Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Peñalver, Francisco‐Javier; Márquez, José‐Antonio; Durán, Soledad; Giraldo, Pilar; Martín, Alejandro; Montalbán, Carlos; Sancho, Juan-Manuel; Ramírez, María José; Terol, María José; Capote Huelva, Francisco Javier; Gutiérrez, Antonio; Sánchez, Blanca; López, Andrés; Salar, Antonio; Rodríguez‐Caravaca, Gil; Canales, Miguel; Caballero, María‐Dolores; GELTAMO (The Spanish Lymphoma Cooperative Group) (WILEY, 2019-10)